A recent study also showed that gli2-induced overexpression of c-Myc is implicated in pancreatic cancer cell resistance to JQ1 and 1-BET151, selective inhibitors of BET bromodomain proteins [67]. The gene discussed is MYC; the disease is pancreatic neoplasm.